NK-104-CR

· Kowa Research Institute, Inc.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for NK-104-CR, covering 2016-01-11 to 2021-05-10. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy & Long-term Safety Comparison Study of NK-104-CR & Livalo® IR With Primary Hyperlipidemia or Mixed Dyslipidemia [Phase 3]

See pricing